Family Life

01.23.09 | FL News Team

The Food and Drug Administration has approved the first human trial of a medical treatment involving embryonic stem cells. According to "The Wall Street Journal," the sure to be controversial approval has gone to California-based Geron Corporation. The effort will involve a stem-cell treatment for spinal cord injuries and could involve up to ten patients.

The approval comes just days after the inauguration of a new president and an expected wind shift when it comes to use of embryonic stem cell research and treatments although both Geron and the FDA claim the timing of the announcement is purely coincidental. 

Embryonic stem cells are the cornerstone of life. They are the cells that transform themselves in the womb into organs, bone, muscle and sinew. While the study approved this week will focus on the safety of stem cell therapy, Geron has reportedly found a way to coax stem cells into transforming themselves into type specific cells.

During the campaign, President Obama announced overturning research limits involving embryonic stem cells imposed by the Bush administration would be a top priority if he were elected to the highest office in the land. Within days of the November election, Obama advisers suggested the new president might use his executive authority to undo the Bush administration ban.